Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Treasury Shares (2016 - 2025)

Standard Biotools (LAB) has disclosed Treasury Shares for 4 consecutive years, with $46.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Treasury Shares changed 0.0% to $46.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $46.5 million, a 0.0% change, with the full-year FY2024 number at $46.5 million, up 677.43% from a year prior.
  • Treasury Shares was $18.6 million for Q3 2025 at Standard Biotools, up from -$18.6 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $18.6 million in Q4 2024 to a low of -$18.6 million in Q1 2025.
  • A 5-year average of $2.7 million and a median of $2.6 million in 2023 define the central range for Treasury Shares.
  • Peak YoY movement for Treasury Shares: surged 961.63% in 2023, then changed 0.0% in 2025.
  • Standard Biotools' Treasury Shares stood at $563000.0 in 2022, then soared by 961.63% to $6.0 million in 2023, then surged by 677.43% to $46.5 million in 2024, then changed by 0.0% to $46.5 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Treasury Shares are $46.5 million (Q3 2025), $46.5 million (Q2 2025), and $46.5 million (Q1 2025).